featured
Dupilumab Use for Atopic Dermatitis Is Associated With Decreased Utilization of Psychostimulants for ADHD
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
Journal of the American Academy of Dermatology
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Dupilumab treatment for atopic dermatitis is associated with decreased utilization of psychostimulants for attention deficit hyperactivity disorder: A retrospective cohort study
J Am Acad Dermatol 2023 Feb 01;[EPub Ahead of Print], AM Yildirim, T Pradhan, ZA ZinnFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.